Birdwatch Note Rating
2024-03-13 08:27:46 UTC - NOT_HELPFUL
Rated by Participant: 66F114B50A6D8BC3C722B4327A4EC5A992E6FE11E2DB189DB8D93D5703A81F10
Participant Details
Original Note:
No, the Ebola clinical trial involving the COVID-19 drug Remdesivir did not show Remdesivir had a 53% mortality rate. This is a false interpretation of the study. The study showed that Ebola infection had a 53% mortality rate. Ebola can have up to a 90% mortality rate https://www.nejm.org/doi/full/10.1056/nejmoa1910993 https://www.paho.org/en/topics/ebola-virus-disease
All Note Details